抑郁症治疗中的SSRI:一个药理上的CUL-DE-SAC?
1Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK. phil.cowen@psych.ox.ac.uk.
Current topics in behavioral neurosciences
|November 3, 2023
概括
选择性血清素再吸收抑制剂 (SSRI) 彻底改变了抑郁症的治疗方法,但也有局限性. 未来的治疗可能涉及新型的血清素和上腺素再吸收抑制剂 (SNRIs) 或组合疗法.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 是一线抑郁症治疗,比三环抗抑郁药 (TCA) 提供更好的安全性.
- 此外,SSRI存在一些局限性,包括延迟的疗效,性功能障碍以及对无情感和认知障碍的不充分治疗.
研究的目的:
- 审查当前抗抑郁药物药物疗法的疗效和局限性.
- 探索抗抑郁药物开发的潜在未来方向.
主要方法:
- 关于SSRI,氨酸和上腺素再吸收抑制剂 (SNRIs) 的文献综述,以及新的治疗策略.
- 分析不同类型抗抑郁药的临床结果和副作用概况.
主要成果:
- 抗抑郁药的效果不大,无法完全解决认知缺陷和无情感.
- 综合使用的血清素和诺亚上腺素再吸收抑制剂 (SNRIs) 显示出极小的疗效增长,但副作用增加.
- 伏尔提奥塞丁在改善与抑郁症相关的认知障碍方面表现有前途.
结论:
- 尽管SSRI广泛使用,但在治疗抑郁症方面存在重大局限性.
- 未来的抗抑郁药物开发可能将重点放在先进的SNRIs或针对特定血清素受体亚型的组合疗法上.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
410
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
410
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Antidepressant Drugs: Overview
524
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
524
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
270
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
270
G-protein Coupled Receptors
119.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
119.9K
Drug Therapy
47
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
47


